We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

GENEART Receives European Patent for Screening Process for Antiviral Therapeutics

News   Feb 06, 2009

 
GENEART Receives European Patent for Screening Process for Antiviral Therapeutics
 
 
Advertisement
 

RELATED ARTICLES

Artificial Genes Sense Cellular Responses to Drugs

News

BUSM researchers have developed and implemented a new way to better understand how human cells communicate with each other, how this communication is disrupted in human diseases and how this can be corrected pharmacologically.

READ MORE

A Watched Pot Never Boils… But That’s Not the Case With DNA

News

Liquid droplets formed from DNA display a peculiar response to enzymes. An international collaboration has now been able to explain the mechanisms behind bubble formation.

READ MORE

Mutated Form of SARS-CoV-2 Is Dominant, But Doesn't Make Patients Sicker, Study Says

News

In a collaborative research study, scientists show that a mutated version of SARS-CoV-2 has become the predominant form across the globe. Whilst the variant competes with the original strain, clinical data suggests that it does not make individuals sicker.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE